Goldman SACHS & Co. LLC, 10% Owner at T2 Biosystems, Inc. (TTOO), bought 46,254 shares at $0.49 ($30K) on 2020-04-09, disclosed to the SEC on 2021-08-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.38 | 500 | $190 | 0.6% |
| 2 | $0.93 | 600 | $558 | 1.9% |
| 3 | $0.49 | 1,000 | $490 | 1.7% |
| 4 | $0.55 | 26,200 | $14K | 48.5% |
| 5 | $0.55 | 2,500 | $1K | 4.6% |
| 6 | $0.83 | 10,328 |
| $9K |
| 28.9% |
| 7 | $0.80 | 5,126 | $4K | 13.8% |
| Total | $0.64 avg | 46,254 | $30K | 100% |
| Filing → |
| NCAC | BUY | 2023-03-08 | $0 | — | Filing → |
| NCAC | SELL | 2023-03-08 | $40K | — | Filing → |
| FLYW | SELL | 2022-11-17 | $15.0M | — | Filing → |